|
PPIL5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.242600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.148400E-01 |
| Normal-vs-Stage2 |
9.959600E-01 |
| Normal-vs-Stage3 |
6.335600E-01 |
| Normal-vs-Stage4 |
1.165220E-01 |
| Stage1-vs-Stage2 |
3.643200E-01 |
| Stage1-vs-Stage3 |
9.031200E-01 |
| Stage1-vs-Stage4 |
2.608800E-01 |
| Stage2-vs-Stage3 |
6.483800E-01 |
| Stage2-vs-Stage4 |
1.279440E-01 |
| Stage3-vs-Stage4 |
3.368000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.958800E-01 |
| Normal-vs-AfricanAmerican |
1.254960E-01 |
| Normal-vs-Asian |
3.596800E-01 |
| Caucasian-vs-AfricanAmerican |
4.073600E-01 |
| Caucasian-vs-Asian |
7.466800E-01 |
| AfricanAmerican-vs-Asian |
9.079400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.889400E-01 |
| Normal-vs-Female |
1.460010E-01 |
| Male-vs-Female |
4.621600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.453400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.366000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.753200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.493000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.373600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.181600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.328000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.452400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.242000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.938600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.351800E-01 |
| Normal-vs-Grade 2 |
2.705200E-01 |
| Normal-vs-Grade 3 |
6.147800E-01 |
| Normal-vs-Grade 4 |
1.596780E-01 |
| Grade 1-vs-Grade 2 |
7.436600E-01 |
| Grade 1-vs-Grade 3 |
9.318000E-01 |
| Grade 1-vs-Grade 4 |
3.791800E-01 |
| Grade 2-vs-Grade 3 |
6.465600E-01 |
| Grade 2-vs-Grade 4 |
3.581200E-01 |
| Grade 3-vs-Grade 4 |
2.791800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.487000E-01 |
| Normal-vs-ccB subtype |
1.836830E-01 |
| ccA subtype-vs-ccB subtype |
2.101800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.852410E-01 |
| Normal-vs-N1 |
5.435000E-01 |
| N0-vs-N1 |
8.693200E-01 |
|
|
